Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes ...

X-Therma’s participation in Hopkins on the Hill underscores the company’s commitment to advancing organ preservation and ...

As research institutions find themselves uncertain about the future of federal funding, startups may soon find those key ...

One senior NIH employee – who asked not to be identified – told Nature that, if the aim is to end overseas funding of research, "but they don't have the law to do that, this is a way they can ...